Enliven Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Enliven Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Enliven Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.41 USD/shares, unchanged year-over-year.
  • Enliven Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -1.75 USD/shares, a 76.3% increase year-over-year.
  • Enliven Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.01 USD/shares, a 83.3% increase from 2022.
  • Enliven Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -12.1 USD/shares, a 12.3% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2 $0 $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$2 -$1 +$0.26 +32.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$2 $0 +$2.62 +90% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 -$5 -$1 +$2.76 +84.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$7 $0 +$2.45 +85.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$10 -$1 +$2.21 +73.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$12 -$3 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$3 -$3 -495% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$3 -$2 -286% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$3 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-25
Q2 2021 -$1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.